Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Jacob M. Keck's research focuses on antimicrobial resistance and the development of new therapeutic strategies. His work has investigated treatment-emergent resistance to cefiderocol in carbapenem-resistant *Acinetobacter baumannii*, linking this resistance to the insertion sequence IS *Aba36* within the siderophore receptor *pirA*. Keck also examines antifungal resistance and the evaluation of antifungal stewardship initiatives, including the use of micafungin. His recent publications explore the challenges and approaches to managing fever in neutropenic patients, the emergence of resistance to new antibiotics, and case series utilizing novel antifungal agents like rezafungin for invasive candidiasis. He has also published on the use of combination therapies, such as aztreonam–avibactam with eravacycline, for complex bacterial infections. Keck's research network includes collaborators such as Ryan K. Dare and Alina Viteri at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 5
- Publications: 8
- Citations: 86
Selected Publications
-
Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae (2025)
-
“Dusting Off the Cobwebs”: Rethinking How We Use New Antibiotics (2025)
-
It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis (2025)
-
New Agents Are Coming, and So Is the Resistance (2024)
-
Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i> (2024)
-
Antifungal resistance, combinations and pipeline: oh my! (2023)
-
Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center (2023)
Collaboration Network
Top Collaborators
- Approach to fever in patients with neutropenia: a review of diagnosis and management
- Antifungal resistance, combinations and pipeline: oh my!
- Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
- Approach to fever in patients with neutropenia: a review of diagnosis and management
- Antifungal resistance, combinations and pipeline: oh my!
- Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
- Approach to fever in patients with neutropenia: a review of diagnosis and management
- Antifungal resistance, combinations and pipeline: oh my!
- Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis
- Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae
- New Agents Are Coming, and So Is the Resistance
- It’s Here, It’s There, There’s Fungi Everywhere: A Case Series Utilizing Rezafungin for Invasive Candidiasis
- “Dusting Off the Cobwebs”: Rethinking How We Use New Antibiotics
- Approach to fever in patients with neutropenia: a review of diagnosis and management
- Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
- Approach to fever in patients with neutropenia: a review of diagnosis and management
- Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
- Approach to fever in patients with neutropenia: a review of diagnosis and management
- Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
- Approach to fever in patients with neutropenia: a review of diagnosis and management
- Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae
- Evaluation of an Antifungal Stewardship Initiative Targeting Micafungin at an Academic Medical Center
- Antifungal resistance, combinations and pipeline: oh my!
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
- Treatment-emergent cefiderocol resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> is associated with insertion sequence IS <i>Aba36</i> in the siderophore receptor <i>pirA</i>
Similar Researchers
Based on overlapping research topics